T1	PROC 46 77	Estudio abierto y multicéntrico
T2	PROC 83 105	evaluar los resultados
T3	CHEM 190 200	ribavirina
#1	AnnotatorNotes T3	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T4	CHEM 202 205	RBV
#2	AnnotatorNotes T4	C0035525; ribavirin; Nucleic Acid, Nucleoside, or Nucleotide · Pharmacologic Substance
T5	DISO 222 270	infección crónica por el virus de la hepatitis C
#3	AnnotatorNotes T5	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
T6	DISO 324 356	Infección crónica de Hepatitis C
T7	DISO 272 275	VHC
#4	AnnotatorNotes T7	C0019196; Hepatitis C; Disease or Syndrome
T8	PROC 542 571	esterilizadas quirúrgicamente
T9	PROC 607 630	métodos anticonceptivos
#5	AnnotatorNotes T9	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T10	PROC 654 683	esterilizados quirúrgicamente
T11	PROC 719 742	métodos anticonceptivos
#6	AnnotatorNotes T11	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T12	DISO 758 786	Infección crónica por el VHC
T13	PHYS 474 495	estado posmenopáusico
#7	AnnotatorNotes T13	C0206159; Postmenopause; Organism Function
T14	DISO 874 909	infección por el genotipo 1 del VHC
T15	CHEM 950 960	medicación
#8	AnnotatorNotes T15	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T16	DISO 1186 1210	descompensación hepática
#9	AnnotatorNotes T16	C0085605; Liver Failure; Disease or Syndrome | C1394798; Hepatic decompensation; Pathologic Function
T17	DISO 1242 1265	carcinoma hepatocelular
#10	AnnotatorNotes T17	C2239176; Liver carcinoma; Neoplastic Process
T18	PROC 1286 1313	trasplante de órgano sólido
#11	AnnotatorNotes T18	C0730400; Solid organ transplant; Therapeutic or Preventive Procedure
T19	CHEM 142 149	ABT 267
T20	CHEM 1030 1038	fármacos
#12	AnnotatorNotes T20	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T21	PROC 1008 1038	administración de los fármacos
T22	ANAT 1202 1210	hepática
#13	AnnotatorNotes T22	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T23	ANAT 1252 1265	hepatocelular
#14	AnnotatorNotes T23	C0227525; Hepatocyte; Cell
T24	ANAT 1300 1306	órgano
#15	AnnotatorNotes T24	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T25	CHEM 124 131	ABT 450
#16	AnnotatorNotes T25	C3712108; ABT-450; Organic Chemical · Pharmacologic Substance
T26	CHEM 132 141	ritonavir
#17	AnnotatorNotes T26	C0292818; ritonavir; Organic Chemical · Pharmacologic Substance
T27	CHEM 151 158	ABT 450
#18	AnnotatorNotes T27	C3712108; ABT-450; Organic Chemical · Pharmacologic Substance
T28	CHEM 161 168	ABT 267
T29	CHEM 172 179	ABT 333
#19	AnnotatorNotes T29	C3850285; ABT-333; Organic Chemical · Pharmacologic Substance
T30	Date 13 17	2014
T31	Date 106 119	a largo plazo
T32	Neg_cue 186 189	sin
T33	LIVB 210 217	adultos
#20	AnnotatorNotes T33	C0001675; Adult; Age Group
T34	Duration 232 239	crónica
#21	AnnotatorNotes T34	C0205191; chronic; Temporal Concept
T35	LIVB 247 270	virus de la hepatitis C
#22	AnnotatorNotes T35	C0220847; hepatitis C virus; Virus
T37	PROC 280 288	genotipo
#23	AnnotatorNotes T37	C1285573; Genotype determination; Laboratory Procedure
T38	Duration 334 341	crónica
#24	AnnotatorNotes T38	C0205191; chronic; Temporal Concept
T39	LIVB 394 399	mujer
#25	AnnotatorNotes T39	C0043210; Woman; Population Group
T40	Age 409 431	edad mínima de 18 años
T41	LIVB 463 470	Mujeres
#26	AnnotatorNotes T41	C0043210; Woman; Population Group
T43	Date 481 495	posmenopáusico
T44	Duration 502 517	al menos 2 años
T45	Duration 768 775	crónica
#27	AnnotatorNotes T45	C0205191; chronic; Temporal Concept
T46	LIVB 783 786	VHC
#28	AnnotatorNotes T46	C0220847; hepatitis C virus; Virus
T47	PROC 891 899	genotipo
#29	AnnotatorNotes T47	C1285573; Genotype determination; Laboratory Procedure
T48	LIVB 906 909	VHC
#30	AnnotatorNotes T48	C0220847; hepatitis C virus; Virus
T49	Duration 979 994	las dos semanas
T50	Date 1108 1116	actuales
T51	Date 1119 1126	pasados
T36	LIVB 386 391	Varón
#31	AnnotatorNotes T36	C0025266; Male population group; Population Group
T42	PROC 1148 1158	Child Pugh
#32	AnnotatorNotes T42	C3854424; Child-Pugh-Turcotte score; Laboratory Procedure
T52	LIVB 646 653	Varones
#33	AnnotatorNotes T52	C0025266; Male population group; Population Group
A1	Assertion T3 Negated
A2	Assertion T4 Negated
A3	Population_data T33 Age
A4	Status T10 History_of
A5	Status T8 History_of
A6	Status T15 History_of
A7	Assertion T15 Contraindicated
A8	Status T16 History_of
A9	Status T18 History_of
#34	AnnotatorNotes T1	C1709323; Open Label Study; Research Activity + C1096776; Multicenter Study; Research Activity
#35	AnnotatorNotes T28	C3713322; ABT-267; Organic Chemical · Pharmacologic Substance
#36	AnnotatorNotes T6	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
#37	AnnotatorNotes T12	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
#38	AnnotatorNotes T14	C4736230; chronic hepatitis C due to hepatitis C virus genotype 1a; Disease or Syndrome
#39	AnnotatorNotes T21	C3469597; Administration of medication; Therapeutic or Preventive Procedure
#40	AnnotatorNotes T31	C0443252; Long-term; Temporal Concept
#41	AnnotatorNotes T50	C0521116; Current (present time); Temporal Concept
#42	AnnotatorNotes T51	C1444637; In the past; Temporal Concept
T53	Observation 1054 1088	Resultados anómalos de laboratorio
#43	AnnotatorNotes T53	C3648370; laboratory tests nonspecific abnormal findings; Finding
T54	CONC 1093 1107	Datos clínicos
#44	AnnotatorNotes T54	C1516606; Clinical Data; Intellectual Product
R1	Overlap Arg1:T54 Arg2:T50	
R2	Overlap Arg1:T54 Arg2:T51	
T55	Result_or_Value 1133 1144	clase B o C
R3	Has_Result_or_Value Arg1:T42 Arg2:T55	
R4	Location_of Arg1:T22 Arg2:T16	
R5	Location_of Arg1:T23 Arg2:T17	
R6	Location_of Arg1:T24 Arg2:T18	
R7	Has_Duration_or_Interval Arg1:T6 Arg2:T38	
R8	Experiences Arg1:T33 Arg2:T4	
R9	Experiences Arg1:T33 Arg2:T3	
R10	Negation Arg1:T32 Arg2:T3	
R11	Negation Arg1:T32 Arg2:T4	
R12	Experiences Arg1:T33 Arg2:T5	
R13	Experiences Arg1:T33 Arg2:T7	
R14	Experiences Arg1:T33 Arg2:T37	
R15	Causes Arg1:T35 Arg2:T5	
R16	Causes Arg1:T35 Arg2:T7	
R17	Has_Duration_or_Interval Arg1:T5 Arg2:T34	
T56	Quantifier_or_Qualifier 280 290	genotipo 1
R18	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T56	
R19	Experiences Arg1:T33 Arg2:T25	
R20	Combined_with Arg1:T25 Arg2:T26	
R21	Combined_with Arg1:T26 Arg2:T19	
R22	Combined_with Arg1:T19 Arg2:T29	
R23	Combined_with Arg1:T29 Arg2:T3	
R24	Combined_with Arg1:T29 Arg2:T4	
R25	Overlap Arg1:T2 Arg2:T31	
R26	Combined_with Arg1:T27 Arg2:T28	
R27	Combined_with Arg1:T28 Arg2:T29	
#45	AnnotatorNotes T19	C3713322; ABT-267; Organic Chemical · Pharmacologic Substance
R28	Has_Age Arg1:T39 Arg2:T40	
R29	Has_Age Arg1:T36 Arg2:T40	
T57	PROC 449 458	selección
#46	AnnotatorNotes T57	C0242802; Patient Selection; Research Activity
R30	Overlap Arg1:T57 Arg2:T40	
R31	Experiences Arg1:T41 Arg2:T13	
R32	Overlap Arg1:T13 Arg2:T43	
R33	Has_Duration_or_Interval Arg1:T13 Arg2:T44	
T58	PROC 530 539	selección
#47	AnnotatorNotes T58	C0242802; Patient Selection; Research Activity
R34	Before Arg1:T13 Arg2:T58	
R35	Experiences Arg1:T41 Arg2:T8	
R36	Experiences Arg1:T41 Arg2:T9	
T59	Quantifier_or_Qualifier 743 753	aceptables
#48	AnnotatorNotes T59	C1879533; Acceptable; Qualitative Concept
R37	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T59	
T60	Quantifier_or_Qualifier 631 641	aceptables
#49	AnnotatorNotes T60	C1879533; Acceptable; Qualitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T60	
R39	Experiences Arg1:T52 Arg2:T10	
R40	Experiences Arg1:T52 Arg2:T11	
T61	Quantifier_or_Qualifier 891 901	genotipo 1
R41	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T61	
R42	Causes Arg1:T48 Arg2:T14	
T62	PROC 850 859	selección
#50	AnnotatorNotes T62	C0242802; Patient Selection; Research Activity
R43	Overlap Arg1:T14 Arg2:T62	
R44	Before Arg1:T15 Arg2:T21	
R45	Overlap Arg1:T15 Arg2:T49	
R46	Used_for Arg1:T20 Arg2:T21	
T63	CONC 799 808	inclusión
#51	AnnotatorNotes T63	C1512693; Inclusion; Qualitative Concept
R47	Before Arg1:T12 Arg2:T63	
R48	Causes Arg1:T46 Arg2:T12	
R49	Has_Duration_or_Interval Arg1:T12 Arg2:T45	
R50	Experiences Arg1:T33 Arg2:T27	
A10	Experiencer T33 Patient
A11	Experiencer T39 Patient
A12	Experiencer T36 Patient
A13	Experiencer T41 Patient
A14	Experiencer T52 Patient
